The maximum tolerated dose has not yet been determined. Pharmacokinetics: Early pharmacokinetic data indicate a median half-life of approximately seven days, potentially enabling bi-weekly dosing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback